Pharmacometrics is a field at the intersection of pharmacology and mathematics, employing quantitative models to understand and predict the behaviour of drugs within the human body. By integrating biological, pharmacological, and physiological data, pharmacometricians develop mathematical models that enhance drug development and dosage optimization. This discipline plays a crucial role in determining the right drug doses for diverse patient populations, considering factors like age, genetics, and disease states. Through advanced modelling techniques, pharmacometrics aids in simulating drug responses, evaluating potential drug interactions, and predicting outcomes under various scenarios. It contributes significantly to personalized medicine, allowing for tailored treatment strategies. The utilization of pharmacometrics in pharmaceutical research and development has streamlined decision-making processes, accelerated drug development timelines, and improved overall patient care. This innovative approach fosters a deeper understanding of drug efficacy and safety, ultimately paving the way for more precise and effective therapeutic interventions.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico